- Evaluation of the MONARCH-2 trial2020 | Faculty of Medicine in Hradec Králové
- Hormonální rezistence u karcinomu prsu a terapie CDK4/6 inhibitory - kazuistika pacientky se sekundární hormonální rezistencí na terapii abemaciclib s fulvestrantem2022 | First Faculty of Medicine
- Cyclin-dependent kinases - a suitable target in metastatic breast cancer2021 | First Faculty of Medicine
- Therapeutic Drug Monitoring of Protein Kinase Inhibitors in Breast Cancer Patients2021 | First Faculty of Medicine
- Strategies for managing endocrine resistance in advanced hormone receptor-positive and HER2-negative breast cancer2017 | First Faculty of Medicine
- CDK4/6 inhibitors in adjuvant therapy of breast cancer2023 | First Faculty of Medicine
- Adjuvant hormone therapy in young women with early breast cancer in 20232023 | Publication without faculty affiliation
- Targeting Pharmacokinetic Drug Resistance in Acute Myeloid Leukemia Cells with CDK4/6 Inhibitors2020 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové